Don't Buy the Slogan. Buy the Constraint.
A quick note from Behind the Markets
Wall Street can't help itself. They turn every trend into a mega-cap story, then sell it back to you at 30x earnings.
But the real economy is changing in a more uncomfortable way.
The U.S. is rebuilding industrial capacity… while capital is expensive, labor is tight, and "free money" subsidies are already getting gamed.
The Fed spoke yesterday afternoon, and the first read on second-quarter GDP hit at 8:30 this morning. You don't need to react to either headline. You need the framework that works regardless of what they said.
1) Reshoring Isn't a Patriotism Story — It's a Pricing Power Story (for the Right Parts of the Chain)
"Reshoring" gets sold like a flag-waving slogan. The market loves that. It's clean.
Reality is uglier. Most new U.S. capacity doesn't show up as a straight-line windfall for the brand names. It shows up as years of capex, procurement bottlenecks, and supplier leverage.
Here's the contrarian angle: the real winners are often the boring companies that make the buildout possible — not the ones doing the ribbon-cutting. What tends to get scarce first: specialized electrical gear, automation and test equipment, industrial gases and chemicals, precision machining and consumables, logistics near new plants.
And sometimes the scarcity shows up somewhere almost comically specific. This year, it showed up in tungsten.
Company: Kennametal (SYM: KMT)
The 88-year-old tungsten-carbide toolmaker — this year's "critical mineral shock" winner. Now the street is brawling over whether it's priced.
Every reshored factory that machines metal — aerospace parts, defense components, engine blocks — consumes cutting tools the way printers consume ink. Kennametal has made those consumables since 1938: tungsten carbide cutting tools, engineered wear components, earth-cutting tools, and advanced metallurgical powders. Consumables are the beautiful part: they wear out on schedule, and the customer's machines stop without them. Demand non-negotiable, supply limited.
This year handed Kennametal exactly that squeeze: a tungsten price shock — tied to Chinese export restrictions on the metal that is literally the company's middle name — through which Kennametal delivered strong growth, sending the stock up more than 50% at one point, enough that Jefferies downgraded to Hold purely on valuation with a $47.50 target. And here's the honest picture of where the fight stands now: the momentum crowd has cooled — Morgan Stanley cut its target to $31, JPMorgan to $34 at Underweight, and Barclays moved to Underweight arguing the tungsten "shock and awe" is fading — while bulls counter that short-cycle industrial demand is improving after an extended slump and Jefferies' $47.50 sits far above the pack. The company also shored up its flexibility with $700 million in fresh liquidity and extended debt maturities.
The two-sided truth: this is a cyclical industrial whose earnings ride machining activity — the pre-tungsten years were a grind of falling revenue — the street's average stance is closer to Hold than Buy, and fiscal fourth-quarter earnings land Wednesday, August 5 — the referee's whistle on the whole tungsten debate, six days after you read this. If you like the critical-minerals consumables story, this print is your entry information. Position accordingly, or wait for it.
Bottom line: Reshoring creates pockets of brutal pricing power — but it usually accrues to the suppliers, not the headlines. Sometimes to suppliers of things you've never once thought about.
2) Subsidies Create Bad Behavior — And Investors Keep Underestimating the Hangover
Any time Washington writes big checks, two things happen: some real projects get built, and a bunch of weak actors show up to skim the edges.
That matters because markets have a bad habit of valuing subsidy-driven growth like it's organic. The tell isn't the press release. It's the cash flow. Ask every "beneficiary": are they earning returns without the incentive? Building a moat, or a future write-down? Locking contracts, or gambling on spot demand?
Now let me show you what it looks like when a company answers those questions the hard way — in public, with a nine-zero check — and gets rewarded for it.
Company: Air Products (SYM: APD)
The 85-year-old industrial-gas giant that just took a $2.9 billion write-down to kill its own subsidy-era moonshots — and the stock went UP.
Air Products is the classic supplier — essential industrial gases and equipment for refining, chemicals, metals, electronics, manufacturing, medical, and food, across roughly 50 countries, with $12 billion in fiscal 2025 sales — the invisible inputs every reshored fab and factory must buy. During the clean-hydrogen gold rush, the prior regime greenlit speculative megaprojects; the new management just cleaned house. In late June, Air Products cancelled the Louisiana Clean Energy Complex and several smaller clean-energy projects, taking pre-tax charges of up to $2.9 billion — roughly $2.2 billion after tax — mostly to write down assets and terminate commitments. The market's verdict on choosing returns over subsidies? The stock rose 12.2% after axing the projects.
And underneath the cleanup, the core engine is humming: fiscal second-quarter adjusted EPS grew 19% year over year, ahead of the company's own guidance, and management raised full-year guidance to $13.00–$13.25, while the remaining flagship — NEOM — gets de-risked through a marketing and distribution agreement with Yara for its renewable ammonia. There's even a bonus geopolitical thread from our energy coverage: the Hormuz disruption has scrambled global helium supply, and Air Products is one of the world's key helium players — a squeeze that cuts through this exact company. The stock trades around $294 with targets from Morgan Stanley at $310 and RBC at $341 (Outperform).
The honest risks: the $2.9 billion charge lands in today's fiscal Q3 report — and headline GAAP numbers will look ugly even though the market pre-digested them; fair-value opinions span an enormous range (roughly $229 to $328); NEOM remains a multi-billion-dollar execution bet in the Saudi desert; and at ~22x forward earnings you're paying quality-compounder prices for a turnaround-in-progress. But as a demonstration of "earning returns without the incentive," there is no cleaner specimen in the market right now.
Bottom line: Government money can juice the story… right up until it exposes who never had a business model. The winners are the ones willing to write the check that admits it.
3) The Quiet "AI Spillover" Trade: Automation, Inspection, and Industrial Software (Not Chatbots)
AI is getting treated like a consumer app. That's the bubble narrative.
The durable money is showing up somewhere else: industrial productivity. Factories and warehouses don't care about "AGI." They care about reducing scrap, catching defects earlier, optimizing energy, scheduling labor, minimizing downtime.
These wins don't require moonshot models. They require deployment, sensors, workflow integration, and accountability. The companies that sell measurable, auditable productivity gains will keep getting renewed even when CFOs get skeptical.
There's one company whose entire 45-year existence is that sentence.
Company: Cognex (SYM: CGNX)
The machine-vision leader — the literal eyes that catch defects on production lines — and its AI story is deployed, not promised.
Cognex builds the cameras and software that locate, identify, inspect, and measure discrete items — phone components, auto parts, e-commerce packages — to automate manufacturing and distribution. "Catching defects earlier" isn't a bullet point here; it's the product itself. And the AI spillover is showing up in the numbers now: first-quarter revenue rose 24% year over year to $268 million with a 22.3% operating margin and adjusted EPS of $0.34 — beating the $0.24 estimate by more than 40% — while the company launched two AI vision platforms, holding $622 million in cash with no debt. It's passes the "renewed when CFOs get skeptical" test: its OneVision AI platform has been used by more than 100 customers since launch, with customers moving from single-line use cases to multi-site rollouts. Single line → whole network is what a proven ROI looks like. Add a new edge-AI vision system built on Qualcomm chips, a $500 million buyback increase, and a street that's warming: 21 analysts average a Buy with a $77.60 target — roughly 34% above the recent price — with Goldman at $80.
The two-sided file: the stock, around $58, is not cheap — Cognex has historically commanded 35–50x earnings, and it earns that multiple only when the cycle cooperates; this is a violently cyclical business tied to consumer-electronics and automotive capex, with meaningful China exposure and a ferocious Japanese competitor in Keyence. The skeptics are represented — Citi sits at Neutral and Truist at Hold even after raising targets. And the calendar: Q2 earnings are due around August 5. Quality franchise, honest cyclicality, AI story you can audit.
Bottom line: The next AI winners might look like boring industrial tech — because that's where the ROI is easiest to prove. And renewals, not demos, are the proof.
4) Higher-for-Longer Turns Industrial America Into a Darwin Market
The market still prices a world where everyone can refinance forever.
That's over.
In an industrial capex cycle with real rates staying elevated, the advantage goes to companies that can self-fund growth, negotiate supplier terms from strength, hold inventory without choking, and survive delays without issuing stock at the bottom.
No ticker for this section — just notice what today's three names have in common beneath their different stories: Kennametal just banked $700 million of extended-maturity flexibility before it needed it; Air Products could absorb a $2.9 billion write-down because the core business gushes cash; Cognex sits on $622 million with zero debt while returning capital. In a Darwin market, that's not conservatism. That's ammunition. Whatever the Fed said yesterday and whatever GDP printed this morning, the companies built like that don't have to care — and the ones renting time do.
Bottom line: In a tight-money industrial boom, capital structure is strategy. Weak hands get diluted. Strong hands buy assets.
Before You Go
Here's your edge as a retail investor: don't buy the slogan. Buy the constraint.
When the U.S. rebuilds factories, the bottleneck isn't optimism. It's tungsten and cutting tools. It's industrial gases. It's the camera that catches the defect before it ships. And behind all of it, it's the balance sheet that survives the wait. Every name above carries the risks — a street fight over tungsten, a nine-zero write-down landing in days, a cyclical multiple — and two of the three report within a week.
Wall Street sells narratives. You now own the map of the constraints.
Found this helpful? Share it with others.
Written by Behind the Markets